The Efficacy and Safety of Irinotecan Plus Temozolomide and Vincristine in Neuroblastoma with Brain Recurrence: A Retrospective Study

被引：0
|
作者：
Wang, J. [1 ]
Zhen, Z. [2 ]
Zhu, S. [3 ]
Lian, Z. [4 ]
Lu, S. [2 ]
Sun, F. [2 ]
Huang, J. [2 ]
Zhang, Y. [5 ]
Sun, X. [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Pediat Oncol, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, Dept Pediat Oncol, Guangzhou, Peoples R China
[3] Capital Med Univ, Natl Ctr Childrens Hlth, Beijing Childrens Hosp, Med Oncol Dept, Beijing, Peoples R China
[4] Sun Yat Sen Univ, Ctr Canc, Pediat Oncol, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Ctr Canc, Dept Pediat Oncol, Guangzhou, Peoples R China
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PV0126
引用
收藏
页码：S213 / S214
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of immune checkpoint inhibitors plus anlotinib in small cell lung cancer with brain metastases: a retrospective, multicentre study
    Zhou, Shujie
    Ren, Fei
    Li, Chaozhuo
    Jiang, Liyang
    Meng, Xiangjiao
    Huang, Zhaoqin
    JOURNAL OF NEURO-ONCOLOGY, 2022, 160 (03) : 631 - 642
  • [42] Phase I study of oral irinotecan and temozolomide in children with relapsed high-risk neuroblastoma: A New Approach to Neuroblastoma Therapy (NANT) Consortium study
    Wagner, L. M.
    Villablanca, J. G.
    Stewart, C. F.
    Crews, K. R.
    O'Shaughnessy, M. A.
    Groshen, S.
    Reynolds, C. P.
    Park, J. R.
    Maris, J. M.
    Matthay, K. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [43] Phase I/II study of 131I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma
    DuBois, S. G.
    Allen, S.
    Bent, M.
    Hilton, J. F.
    Hollinger, F.
    Hawkins, R.
    Courtier, J.
    Mosse, Y. P.
    Matthay, K. K.
    BRITISH JOURNAL OF CANCER, 2015, 112 (04) : 644 - 649
  • [44] Phase I/II study of 131I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma
    S G DuBois
    S Allen
    M Bent
    J F Hilton
    F Hollinger
    R Hawkins
    J Courtier
    Y P Mosse
    K K Matthay
    British Journal of Cancer, 2015, 112 : 644 - 649
  • [45] Efficacy and safety of nanoliposomal irinotecan plus fluorouracil and folinic acid after irinotecan-based chemotherapy in patients with advanced pancreatic cancer: Results of the retrospective part of the NAPOLEON-2 study.
    Kawaguchi, Yasunori
    Aikawa, Tomomi
    Shimokawa, Mototsugu
    Otsuka, Taiga
    Shibuki, Taro
    Nakazawa, Junichi
    Arima, Shiho
    Miwa, Keisuke
    Koga, Futa
    Ueda, Yujiro
    Kubotsu, Yoshihito
    Shimokawa, Hozumi
    Takeshita, Shigeyuki
    Nishikawa, Kazuo
    Hosokawa, Ayumu
    Oda, Hisanobu
    Sakai, Tatsunori
    Shirakawa, Tsuyoshi
    Mizuta, Toshihiko
    Mitsugi, Kenji
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 705 - 705
  • [46] Efficacy of Bevacizumab Alone or in Combination with Temozolomide and Irinotecan in the Treatment of Recurrent and Refractory Brain Tumors in Children in Lebanon
    Noun, P.
    Fadlallah, M.
    Hmaimess, G.
    Younis, J. Abi
    Hage, P.
    Al Hamod, D.
    Mansour, H.
    Bechara, E.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S554 - S555
  • [47] Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
    DuBois, Steven G.
    Chesler, Louis
    Groshen, Susan
    Hawkins, Randall
    Goodarzian, Fariba
    Shimada, Hiroyuki
    Yanik, Greg
    Tagen, Michael
    Stewart, Clinton
    Mosse, Yael P.
    Maris, John M.
    Tsao-Wei, Denice
    Marachelian, Araz
    Villablanca, Judith G.
    Matthay, Katherine K.
    CLINICAL CANCER RESEARCH, 2012, 18 (09) : 2679 - 2686
  • [48] Lack of efficacy of bevacizumab plus irinotecan in cases of pediatric recurrent ependymoma - a Pediatric Brain Tumor Consortium study
    Gururangan, Sridharan
    Fangusaro, Jason
    Poussaint, Tina Young
    Onar-Thomas, Arzu
    Gilbertson, Richard J.
    Vajapeyam, Sridhar
    Gajjar, Amar
    Goldman, Stewart
    Friedman, Henry S.
    Packer, Roger J.
    Boyett, James M.
    Kun, Larry E.
    NEURO-ONCOLOGY, 2012, 14 (11) : 1404 - 1412
  • [49] Phase I study of vincristine, irinotecan, and 131I-MIBG for patients with relapsed or refractory neuroblastoma: A New Approach to Neuroblastoma Therapy (NANT) study.
    DuBois, S. G.
    Chesler, L.
    Groshen, S. G.
    Hawkins, R.
    Goodarzian, F.
    Yanik, G. A.
    Stewart, C. F.
    Mosse, Y. P.
    Maris, J. M.
    Villablanca, J.
    Matthay, K. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] THE EFFICACY AND SAFETY ANALYSIS OF SUNITINIB PLUS TEMOZOLOMIDE THERAPY IN PATIENTS WITH METASTATIC MUCOSAL MELANOMA
    Tang, Bixia
    Chi, Zhihong
    Cui, Chuanliang
    Si, Lu
    Sheng, Xinan
    Kong, Yan
    Mao, Lili
    Lian, Bin
    Li, Siming
    Wang, Xuan
    Yan, Xieqiao
    Guo, Jun
    ANTICANCER RESEARCH, 2015, 35 (07) : 4354 - 4355
12345